JNJ - Johnson & Johnson logo

JNJ

Johnson & Johnson

Johnson & Johnson develops, manufactures, and sells pharmaceuticals, medical devices, and eye care products, including prescription medication for various diseases and surgical tools for healthcare professionals, with distribution through hospitals and retailers.

βš•οΈ Healthcare NYSE Listed 1944 $ USD
$1,000 invested 30 years ago β†’$20,672today

Score Overview

1 Year
Score
Net Growth-21.50%
Net TrendShrank
Net Income Consistencyβ€”
Rev Growth2.30%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score5.8
Net Growth0.78%
Net Trend40%
Net Income Consistencyβ€”
Rev Growth22.38%
Rev TrendEvery year
Revenue Consistencyβ€”
10 Years
Score
Net Growth27.21%
Net Trend40%
Net Income Consistency
Rev Growth34.04%
Rev Trend90%
Revenue Consistency
20 Years
Score5.1
Net Growth90.36%
Net Trend50%
Net Income Consistency
Rev Growth80.71%
Rev Trend80%
Revenue Consistency
30 Years
Score
Net Growth7x
Net Trend63%
Net Income Consistency
Rev Growth345.71%
Rev Trend87%
Revenue Consistency
All Time
Score
Net Growth34x
Net Trend68%
Net Income Consistency
Rev Growth15x
Rev Trend90%
Revenue Consistency

See the full market ranking β†’

Johnson & Johnson fundamental performance

Between 2020 and 2025, revenue grew from $ 82.58B to $ 94.19B and net income grew from $ 14.71B to $ 26.80B. Revenue increased in every one of those 5 years; net income in 2.

Across Johnson & Johnson's full reported history, from 1985 to 2025, revenue grew from $ 6.42B to $ 94.19B and net income grew from $ 613M to $ 26.80B. Revenue increased in 90% of the years measured; net income in 68%.

Johnson & Johnson currently holds a 20-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 260.86β€”
1 Year2025-08-12
$ 168.5554.77%
5 Years2021-08-12
$ 152.2071.39%
10 Years2016-08-12
$ 93.71178.36%
20 Years2006-08-11
$ 35.567x
30 Years1996-08-12
$ 12.6220x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 96.36B$ 21.04B$ 22.05B
2025$ 94.19B$ 26.80B$ 20.10B
2024$ 88.82B$ 14.06B$ 24.52B
2023$ 85.15B$ 35.15B$ 22.92B
2022$ 79.99B$ 17.94B$ 22.28B
2021$ 78.74B$ 20.87B$ 31.60B
2020$ 82.58B$ 14.71B$ 25.18B
2019$ 82.05B$ 15.11B$ 19.28B
2018$ 81.58B$ 15.29B$ 19.68B
2017$ 76.45B$ 1.30B$ 18.29B
2016$ 71.89B$ 16.54B$ 41.90B
2015$ 70.07B$ 15.40B$ 38.37B
2014$ 74.33B$ 16.32B$ 33.08B
2013$ 71.31B$ 13.83B$ 29.20B
2012$ 67.22B$ 10.85B$ 21.08B
2011$ 65.03B$ 9.67B$ 32.26B
2010$ 61.58B$ 13.33B$ 27.65B
2009$ 61.89B$ 12.26B$ 19.42B
2008$ 63.74B$ 12.94B$ 12.80B
2007$ 61.09B$ 10.57B$ 9.31B
2006$ 53.32B$ 11.05B$ 4.08B
2005$ 50.51B$ 10.06B$ 16.13B
2004$ 47.34B$ 8.18B$ 12.88B
2003$ 41.86B$ 7.19B$ 9.52B
2002$ 36.29B$ 6.59B$ 7.47B
2001$ 32.31B$ 5.66B$ 7.97B
2000$ 29.17B$ 4.95B$ 6.75B
1999$ 28.00B$ 4.27B$ 3.87B
1998$ 23.99B$ 3.00B$ 2.78B
1997$ 22.62B$ 3.30B$ 2.75B
1996$ 21.62B$ 2.88B$ 2.01B
1995$ 18.84B$ 2.40B$ 1.20B
1994$ 15.73B$ 2.00B$ 636M
1993$ 14.13B$ 1.78B$ 372M
1992$ 13.75B$ 1.03B$ 745M
1991$ 12.44B$ 1.46B$ 589M
1990$ 11.23B$ 1.14B$ 826M
1989$ 9.75B$ 1.08B$ 452M
1988$ 9.00B$ 974M$ 660M
1987$ 8.01B$ 833M$ 741M
1986$ 7.00B$ 329M$ 952M
1985$ 6.42B$ 613M$ 735M

Explore beyond JNJ

You're looking at Johnson & Johnson. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies